Among the highlights of WCLC are final overall survival (OS) data from AstraZeneca's FLAURA 2 study of EGFR inhibitor ...

Compounded versions of Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) and Lilly's dual GLP-1/GIP agonist Zepbound ...

Compounded versions of Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) and Lilly's dual GLP-1/GIP agonist Zepbound ...

NRG's R&D pipeline is focused on brain-penetrant, small-molecule inhibitors of the mitochondrial permeability transition pore ...

The French drugmaker is paying up to $450 million for rights to KER-0193, a small-molecule modulator of BK channels, a type ...

This is why partnering with an impactful and scalable global Medical Information (MI) team is important in geographical expansion. A trusted MI partner ensures compliance with global and local ...

AI is already rapidly redefining how we discover and design biologics, and as CTO at Cytiva, I’ve had the privilege of ...

Michael Osterholm, director at the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota ...

Menopause is a natural process that occurs as women age and marks the end of their reproductive years. However, while it's a ...

Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.

Ametris has launched a collaboration with pharma companies that aims to show how digital endpoints can be used to advance the ...

The Watertown-based company – set up by Loxo Oncology founder Josh Bilenker and Jeff Engelman, formerly head of oncology at ...